These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. How safe is it to give parenteral iron to a patient with rheumatoid arthritis (RA) and iron deficiency anaemia? Merry P; Kidd B; Blake DR Br J Rheumatol; 1989 Feb; 28(1):22. PubMed ID: 2917225 [No Abstract] [Full Text] [Related]
3. Fatal anaphylaxis after intravenous iron dextran. Zipf RE J Forensic Sci; 1975 Apr; 20(2):326-33. PubMed ID: 1123602 [TBL] [Abstract][Full Text] [Related]
4. Iron-dextran anaphylaxis: occurrence after a negative test dose. Lewinter P J Med Soc N J; 1970 Mar; 67(3):116-7. PubMed ID: 5264625 [No Abstract] [Full Text] [Related]
5. Studies on sudden fatalities among piglets following parenteral iron therapy. Lindvall S; Moberg G; Nordblom B Acta Vet Scand; 1972; 13(2):206-17. PubMed ID: 4652523 [TBL] [Abstract][Full Text] [Related]
6. Successful administration of iron dextran in a patient who experienced a life threatening reaction to intravenous iron dextran. Hickman MA; Bernstein IL; Palascak JE Ann Allergy Asthma Immunol; 2000 Feb; 84(2):262-3. PubMed ID: 10719785 [No Abstract] [Full Text] [Related]
7. Reactions to total dose infusion of iron dextran in rheumatoid arthritis. Lloyd KN; Williams P Br Med J; 1970 May; 2(5705):323-5. PubMed ID: 5429451 [TBL] [Abstract][Full Text] [Related]
8. Pulmonary edema: atypical anaphylactoid reaction to intravenous iron dextran. Freter S; Davidman M; Lipman M; Bercovitch D Am J Nephrol; 1997; 17(5):477-9. PubMed ID: 9382172 [TBL] [Abstract][Full Text] [Related]
9. Iron dextran-induced anaphylaxis in a goat (Capra hircus). Ladiges WC; Garlinghouse LE Lab Anim Sci; 1981 Aug; 31(4):421-2. PubMed ID: 7311471 [No Abstract] [Full Text] [Related]
10. An anaphylactic reaction complicating total dose infusion therapy of iron deficiency. Hart GD; Soots M Appl Ther; 1969 Dec; 11(12):645-6. PubMed ID: 5364340 [No Abstract] [Full Text] [Related]
11. [Parenteral iron therapy: problems and possible solutions]. Hoigné R; Breymann C; Künzi UP; Brunner F Schweiz Med Wochenschr; 1998 Apr; 128(14):528-35. PubMed ID: 9592894 [TBL] [Abstract][Full Text] [Related]
12. Adverse reactions to total-dose infusion of iron dextran. Shimada A Clin Pharm; 1982; 1(3):248-9. PubMed ID: 7185520 [No Abstract] [Full Text] [Related]
13. High-molecular weight iron dextran: a wolf in sheep's clothing? Rodgers GM; Auerbach M; Cella D; Chertow GM; Coyne DW; Glaspy JA; Henry DH J Am Soc Nephrol; 2008 May; 19(5):833-4. PubMed ID: 18369084 [No Abstract] [Full Text] [Related]
14. Anaemia of rheumatoid arthritis and iron therapy. Hume R; Currie WJ; Tennant M Ann Rheum Dis; 1965 Sep; 24(5):451-7. PubMed ID: 4158022 [No Abstract] [Full Text] [Related]
15. The adverse effect of intravenous iron-dextran in rheumatoid arthritis. Reddy PS; Lewis M Arthritis Rheum; 1969 Aug; 12(4):454-7. PubMed ID: 5805282 [No Abstract] [Full Text] [Related]
16. Acute, severe and anaphylactoid reactions are very rare with low-molecular-weight iron dextran, CosmoFer. Vaage-Nilsen O Nephrol Dial Transplant; 2008 Oct; 23(10):3372; author reply 3372. PubMed ID: 18511609 [No Abstract] [Full Text] [Related]
20. Is low-molecular weight iron dextran really the most risky iron?--Unconvincing data from an unconvincing study. DeLoughery TG; Auerbach M Am J Hematol; 2016 May; 91(5):451-2. PubMed ID: 26873795 [No Abstract] [Full Text] [Related] [Next] [New Search]